ARTICLE | Company News
Affibody, Algeta deal
May 16, 2011 7:00 AM UTC
Algeta received exclusive, worldwide rights to two Affibody carrier molecules targeting epidermal growth factor receptor 2 ( EGFR2; HER2; ErbB2; neu) and platelet derived growth factor receptor B ...